Taysha Gene Therapies (TSHA)
Nasdaq • TSHA • US8776191061
ORTEX Data Highlights
ORTEX Data Highlights
As of Oct 22, 2026, ORTEX estimated 23.7% of free float sold short, 11.4 days to cover, cost to borrow 0.44%. Sign up for live short interest data.
Market Cap
1.41b USD | # 4448 in US
Volume
3.6m shares | 18.02m USD
Shares Outstanding
325.83m
Free Float Shares
71.39% | 232.62m
